46622 research outputs found
Sort by
Concerning Changes to the Membership of the Board of Commissioners of the Colorado State Fair Authority
No full texthttps://scholar.law.colorado.edu/session-laws-2001-2050/10397/thumbnail.jp
Concerning Authorization to Enter the Premises of an Establishment That Provides Services Related to Dead Human Bodies in Order to Perform an Inspection
No full texthttps://scholar.law.colorado.edu/session-laws-2001-2050/10388/thumbnail.jp
Concerning the Enactment of the Colorado Revised Statutes 2021 as the Positive and Statutory Law of the State of Colorado
No full texthttps://scholar.law.colorado.edu/session-laws-2001-2050/10359/thumbnail.jp
A Multicenter Weighted Lottery to Equitably Allocate Scarce COVID-19 Therapeutics
No full textShortages of new therapeutics to treat coronavirus disease (COVID-19) have forced clinicians, public health officials, and health systems to grapple with difficult questions about how to fairly allocate potentially life-saving treatments when there are not enough for all patients in need. Shortages have occurred with remdesivir, tocilizumab, monoclonal antibodies, and the oralantiviral Paxlovid.
Ensuring equitable allocation is especially important in light of the disproportionate burden experienced during the COVID-19 pandemic by disadvantaged groups, including Black, Hispanic/Latino and Indigenous communities, individuals with certain disabilities, and low-income persons. However, many health systems have resorted to first-come, first-served approaches to allocation, which tend to disadvantage individuals with barriers in access to care.There is mounting evidence of racial, ethnic, and socioeconomic disparities in access to medications for COVID-19
Reserve System Design for Allocation of Scarce Medical Resources in a Pandemic: Some Perspectives from the Field
No full textHow to Fairly Allocate Scarce COVID-19 Therapies
No full textVaccines are no longer our only medical intervention for preventing severe COVID-19. Over the past few months, we have seen the arrival and wider availability of treatments such as monoclonal antibodies (mAbs), and more recently, of novel oral antiviral drugs like Paxlovid and molnupiravir. The recent Delta and Omicron surges have made these therapies scarce
In the Line for Scarce Covid Treatments, Immunocompromised Americans Should Go Before the Unvaccinated
No full textAt a moment when COVID-19 hospitalizations are high and treatments for the disease scarce, here\u27s an ethical question: Should people who have refused coronavirus vaccines be allowed to compete for treatments with people who are immunocompromised?
We think no. Doing so would be unfair to Americans who remain unprotected by vaccines through no choice of their own
Why the FDA Was Wrong to Delay Authorization of Vaccines for Kids Under 5
No full textThe Food and Drug Administration made the wrong call when it announced last week that it will delay authorization of the Pfizer-BioNTech vaccine for children under 5.
The move is likely to leave young children without access to the shots for two months or more. The FDA and Centers for Disease Control and Prevention should be removing roadblocks to vaccinating young children, not erecting them
